The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Epidemiology and etiology of gliomas
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Globocan 2000 : cancer incidence, mortality and prevalence worldwide
Ferlay, J., Pisani, P., & Parkin, D. M. (2001) · Medical Entomology and Zoology · Cited by 1,579
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Pathology and genetics of tumours of the nervous system.
Kleihues, P., & Cavennee, W. (2000) · International Agency for Research on Cancer eBooks · Cited by 1,432
Self-citationVon Recklinghausen Neurofibromatosis
Riccardi, V. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112313052704 · Cited by 1,344
Genetic Pathways to Glioblastoma
Ohgaki, H., Dessen, P., Jourde, B., Horstmann, S., Nishikawa, T., Di Patre, P.-L., Burkhard, C., Schüler, D., Probst-Hensch, N. M., Maiorka, P. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1337 · Cited by 1,270
Self-citationEndogenous DNA damage in humans: a review of quantitative data
De Bont, R. (2004) · Mutagenesis · doi:10.1093/mutage/geh025 · Cited by 1,058
Ohshima, H., & Bartsch, H. (1994) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(94)90245-3 · Cited by 1,055
Cited by
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
“Patients with GBM have a uniformly poor prognosis, with a median survival of one year (Ohgaki and Kleihues, 2005); thus, advances on all scientific and clinical fronts are needed.”
Genetic Pathways to Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070011 · Cited by 1,497
Self-citationOhgaki, H., & Kleihues, P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.479 · Cited by 1,381
Self-citationHanif, F., Muzaffar, K., Perveen, K., Malhi, S. M., & Sımjee, S. U. (2017) · PubMed · doi:10.22034/apjcp.2017.18.1.3 · Cited by 1,231
The Definition of Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3002 · Cited by 1,132
Self-citationEpidemiology and molecular pathology of glioma
Schwartzbaum, J. A., Fisher, J. L., Aldape, K. D., & Wrensch, M. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0289 · Cited by 949
Goodenberger, M. L., & Jenkins, R. B. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.10.009 · Cited by 846
Lipid nanocapsules: A new platform for nanomedicine
Huynh, N. T., Passirani, C., Saulnier, P., & Benoit, J. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.026 · Cited by 595
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
Ichimura, K., Pearson, D. M., Kocialkowski, S., Bäcklund, L. M., Chan, R., Jones, D. T. W., & Collins, V. P. (2009) · Neuro-Oncology · doi:10.1215/15228517-2009-025 · Cited by 595
Rong, Y., Durden, D. L., Van Meir, E. G., & Brat, D. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00001 · Cited by 567
Current concepts and management of glioblastoma
Preusser, M., de Ribaupierre, S., Wöhrer, A., Erridge, S. C., Hegi, M., Weller, M., & Stupp, R. (2011) · Annals of Neurology · doi:10.1002/ana.22425 · Cited by 461
Stupp, R., Hegi, M. E., Neyns, B., Goldbrunner, R., Schlegel, U., Clement, P. M. J., Grabenbauer, G. G., Ochsenbein, A. F., Simon, M., Dietrich, P.-Y., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6650 · Cited by 454
Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma
Ahir, B. K., Engelhard, H. H., & Lakka, S. S. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01892-8 · Cited by 424
Childhood Brain Tumor Epidemiology: A Brain Tumor Epidemiology Consortium Review
Johnson, K. J., Cullen, J., Barnholtz-Sloan, J. S., Ostrom, Q. T., Langer, C. E., Turner, M. C., McKean-Cowdin, R., Fisher, J. L., Lupo, P. J., Partap, S., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0207 · Cited by 393
IDH mutations in glioma and acute myeloid leukemia
Dang, L., Jin, S., & Su, S. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.002 · Cited by 370
Wnt/β-catenin-driven EMT regulation in human cancers
Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05099-7 · Cited by 321
Risk factors for childhood and adult primary brain tumors
Ostrom, Q. T., Fahmideh, M. A., Cote, D. J., Muskens, I. S., Schraw, J. M., Scheurer, M. E., & Bondy, M. L. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz123 · Cited by 314
Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review
Braganza, M. Z., Kitahara, C. M., Berrington de Gonzalez, A., Inskip, P. D., Johnson, K. J., & Rajaraman, P. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos208 · Cited by 303
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
Allard, E., Passirani, C., & Benoit, J.-P. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.003 · Cited by 294
Guo, X., Qiu, W., Liu, Q., Qian, M., Wang, S., Zhang, Z., Gao, X., Chen, Z., Xue, H., & Li, G. (2018) · Oncogene · doi:10.1038/s41388-018-0261-9 · Cited by 287
Raub, T. J., Wishart, G. N., Kulanthaivel, P., Staton, B. A., Ajamie, R. T., Sawada, G. A., Gelbert, L. M., Shannon, H. E., Sanchez-Martinez, C., & De Dios, A. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062745 · Cited by 284
“Glioblastoma is the most common primary brain tumor; despite improvements in detection and treatment, the 5-year survival for patients with glioblastoma is less than 3% (Ohgaki and Kleihues, 2005).”
BackgroundRasmussen, B. K., Hansen, S., Laursen, R. J., Kosteljanetz, M., Schultz, H., Nørgård, B. M., Guldberg, R., & Gradel, K. O. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2607-5 · Cited by 280
Review Glioblastoma multiforme – an overview
Urbańska, K., Sokołowska, J., Szmidt, M., & Sysa, P. (2014) · Współczesna Onkologia · doi:10.5114/wo.2014.40559 · Cited by 276
Clinical trial links oncolytic immunoactivation to survival in glioblastoma
Ling, A. L., Solomon, I. H., Landivar, A. M., Nakashima, H., Woods, J. K., Santos, A., Masud, N., Fell, G., Mo, X., Yilmaz, A. S., et al. (2023) · Nature · doi:10.1038/s41586-023-06623-2 · Cited by 276
Mamelak, A. N., & Jacoby, D. B. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.2.175 · Cited by 273
Mao, H., LeBrun, D. G., Yang, J., Zhu, V. F., & Li, M. (2012) · Cancer Investigation · doi:10.3109/07357907.2011.630050 · Cited by 266
Wesolowska, A., Kwiatkowska, A., Slomnicki, L., Dembinski, M., Master, A., Sliwa, M., Franciszkiewicz, K., Chouaib, S., & Kaminska, B. (2008) · Oncogene · doi:10.1038/sj.onc.1210683 · Cited by 258
El-Jawahri, A., Podgurski, L. M., Eichler, A. F., Plotkin, S. R., Temel, J. S., Mitchell, S. L., Chang, Y., Barry, M. J., & Volandes, A. E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.7502 · Cited by 256
Isocitrate dehydrogenase-1 mutations: A fundamentally new understanding of diffuse glioma?
Kloosterhof, N. K., Bralten, L. B., Dubbink, H. J., French, P. J., & van den Bent, M. J. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70053-x · Cited by 222
Skalsky, R. L., & Cullen, B. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024248 · Cited by 170
Allergy and risk of glioma: a meta-analysis
Chen, C., Xu, T., Chen, J., Zhou, J., Yan, Y., Lu, Y., & Wu, S. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03187.x · Cited by 100
Clinical significance of Polycomb gene expression in brain tumors
Crea, F., Hurt, E. M., & Farrar, W. L. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-265 · Cited by 70
The Role of Micro RNAs in Regulating PI3K/AKT Signaling Pathways in Glioblastoma
Ghaffarian Zirak, R., Tajik, H., Asadi, J., Hashemian, P., & Javid, H. (2022) · Iranian Journal of Pathology · doi:10.30699/ijp.2022.539029.2726 · Cited by 17
Rimmer, B., Dutton, L., Lewis, J., Burns, R., Gallagher, P., Williams, S., Araujo-Soares, V., Finch, T., & Sharp, L. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-041465 · Cited by 12
A bird's eye view to the homeostatic, Alzheimer and Glioblastoma attractors
Nieves, J., Gil, G., & Gonzalez, A. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42445
Metadata
- Authors
- Ohgaki, H., & Kleihues, P.
- Venue
- Acta Neuropathologica
- Published
- 2005-01
- Volume
- 109
- Issue
- 1
- Pages
- 93-108
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2055475004
- Cited by
- 1,252
- References
- 101
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.